Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03657433 · ClinicalTrials.gov registry record · Phase 3

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

A Phase 3 study of Iron Deficiency Anemia of Pregnancy, sponsored by University of Arizona.

Completed
Registry status
Phase 3
Development phase
124
Enrollment target
1
Study location

NCT03657433 is a Phase 3 study of Iron Deficiency Anemia of Pregnancy that has completed, run by University of Arizona. The registered enrollment target is 124 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03657433, a Phase 3 study of Iron Deficiency Anemia of Pregnancy, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
Phase 3
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

This randomized controlled trial includes pregnant women with anemia. They are randomized to IV iron infusions or to oral iron supplementation. Pregnancy outcomes are assessed.

Interventions

  • DRUG Ferumoxytol
  • DIETARY_SUPPLEMENT Ferrous sulfate 325mg

Study Locations (1)

Arizona

  • University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2018-12-17
Est. Completion 2022-04-01
Phase Phase 3

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03657433

The ClinicalTrials.gov registry entry for NCT03657433 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Iron Deficiency Anemia of Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Ferumoxytol is the first listed.

NCT03657433 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03657433 about?

NCT03657433 is a clinical study titled "Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy". This randomized controlled trial includes pregnant women with anemia. They are randomized to IV iron infusions or to oral iron supplementation. Pregnancy outcomes are assessed.

What is the current status of trial NCT03657433?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 124 participants. The study started on 2018-12-17. Estimated completion is 2022-04-01.

What conditions does trial NCT03657433 study?

This clinical trial studies the following conditions: Iron Deficiency Anemia of Pregnancy.

What interventions are being tested in trial NCT03657433?

The interventions under investigation include: Ferumoxytol (DRUG), Ferrous sulfate 325mg (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03657433?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03657433 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Iron Deficiency Anemia of Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.